Health Economic Outcomes in the Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Randomized Trial
D. Mark{1}, Y. Li{2}, D. Chew{3}, K. Anstrom{4}, E. A. Bohula{5}, D. Thibault{2}, M. Daniels{6}, A. H. Harrington{7}, R. P. Giugliano{8}, M. S. Sabatine{9}; {1}Duke Univ Medical Ctr, Chapel Hill, NC, {2}Duke Clinical Research Institute, Durham, NC, {3}University of Calgary, Calgary, AB, CANADA, {4}University of North Carolina, Chapel Hill, NC, {5}Brigham And Womens Hospital, Boston, MA, {6}Duke University, Durham, NC, {7}DCRI, Durham, NC, {8}Brigham and Women's Hospital, Boston, MA, {9}Brigham and Womens Hospital, Boston, MA.
